Natural Capsules Ltd
Mon 15/06/2026,14:33:55 | NSE : NATCAPSUQ
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 154.25
Previous Close
₹ 155.95
Volume
8943
Mkt Cap ( Rs. Cr)
₹160.85
High
₹ 157.35
Low
₹ 150.00
52 Week High
₹ 296.00
52 Week Low
₹ 136.36
Book Value Per Share
₹ 212.91
Dividend Yield
0.00
Face Value
₹ 10.00
What’s Your Call?
Collective community sentiment on Natural Capsules Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
4 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
52%
Sell Order Quantity
48%
Bid Price
Qty
153.00
101
153.00
10
153.00
20
152.00
1
152.00
39
Bid Total
6755
Bid Price
Qty
154.39
18
154.00
47
155.00
5
155.00
530
155.00
2000
Bid Total
6322
Option Chain
Analyzes market sentiment, predicts Natural Capsules Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Natural Capsules - Disclosure under SEBI Takeover Regulations
-
Natural Capsules - Analysts/Institutional Investor Meet/Con. Call Updates
-
Natural Capsules - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Natural Capsules - Analysts/Institutional Investor Meet/Con. Call Updates
-
Natural Capsules - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Natural Capsules - General Updates
-
Natural Capsules - Analysts/Institutional Investor Meet/Con. Call Updates
-
Natural Capsules - Corrigendum To The Intimation Under Regulation 30(9) Of SEBI (LODR) Regulations, 2015 Dated May\r\n27, 202
-
Natural Capsules - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Natural Capsules - Investor Presentation
-
Natural Capsules - Press Release
-
Natural Capsules - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Natural Capsules - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Natural Capsules - Analysts/Institutional Investor Meet/Con. Call Updates
-
Natural Capsules - Change in Company Secretary/Compliance Officer
-
Natural Capsules - Appointment of Company Secretary and Compliance Officer
-
Natural Capsules - Intimation Under Regulation 30(9) Of SEBI (LODR) Regulations, 2015.
-
Natural Capsules - General Updates
-
Natural Capsules - ESOP/ESOS/ESPS
-
Natural Capsules Q4 net profit zooms 109.89% at Rs 5.52 cr
-
Natural Capsules - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
-
Natural Capsules - Announcement under Regulation 30 (LODR)-Change in Management
-
Natural Capsules - Outcome of Board Meeting
-
Natural Capsules - Outcome of Board Meeting
-
Natural Capsules - Outcome of Board Meeting
-
Natural Capsules - Approved The Audited Standalone And Consolidated Financial Results For The Quarter And Financial Year\r\nE
-
Natural Capsules - Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, May 27, 2026.
-
Natural Capsules - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday, May 27, 2026 Of The Comp
-
Natural Capsules - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
-
Natural Capsules - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
-
Natural Capsules - Resignation of Director/KMP/SMP
-
Natural Capsules - Resignation of Director/KMP/SMP
-
Natural Capsules - Announcement under Regulation 30 (LODR)-Cessation
-
Natural Capsules - Cessation
-
Natural Capsules - Copy of Newspaper Publication
-
Natural Capsules - General Updates
-
Natural Capsules - Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015, Intimation Regarding Second 100 Days Ca
-
Natural Capsules has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026
-
Natural Capsules - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Natural Capsules - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Natural Capsules - Copy of Newspaper Publication
-
Natural Capsules - Shareholders meeting
-
Natural Capsules - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report
-
Natural Capsules - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
-
Natural Capsules - Trading Window
-
Natural Capsules - Credit Rating
-
Natural Capsules - Announcement under Regulation 30 (LODR)-Credit Rating
Key fundamentals
Evaluate the intrinsic value of Natural Capsules Ltd stock
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 237.8342 | 221.3278 | 193.8159 | 173.2095 | 114.1357 |
| Liabilities | 237.8342 | 221.3278 | 193.8159 | 173.2095 | 114.1357 |
| Equity | 10.3862 | 10.3412 | 9.3318 | 9.2755 | 7.0118 |
| Gross Profit | 21.3322 | 19.2998 | 20.7658 | 35.4301 | 25.4914 |
| Net Profit | 11.2138 | 6.7111 | 7.805 | 19.1983 | 13.9539 |
| Cash From Operating Activities | 36.1565 | 18.0289 | 5.3973 | 20.1067 | 5.0921 |
| NPM(%) | 6.45 | 3.99 | 5.07 | 11.1 | 10.33 |
| Revenue | 173.7709 | 167.9382 | 153.8063 | 172.868 | 135.065 |
| Expenses | 152.4387 | 148.6384 | 133.0405 | 137.4379 | 109.5736 |
| ROE(%) | 5.05 | 3.02 | 3.52 | 8.66 | 6.29 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Natural Capsules Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 730.00 | 0.61 | 0.00 | 86.84 | -26.19 | 0.68 |
| Lotus Eye Hospital and Institute Ltd | 141.80 | 4.96 | 4726.67 | 316.42 | 0.39 | 0.00 |
| Vaishali Pharma Ltd | 7.16 | 0.28 | 23.10 | 1984.98 | 15.96 | 0.00 |
| Astec Lifesciences Ltd | 768.85 | -0.10 | 0.00 | 298.39 | -363.14 | 0.00 |
Company Info
YEAR EVENTS 1993 - Natural Capsules Limited was incorporated as a Public Limited Copmany on 20th September with the Registrar of Companies, Karnataka at Bangalore. The company has obtained the Certificate of Commencement of business on the 19th January 1994. - The immediate objective of the company is to set up manufacturing facilities for manufacture of Empty Hard Gelatine Capsules with an installed capacity of 980 million Nos. per annum. 1995 - The Company has acquired land admeasuring 8165 sq. mtrs. from Karnataka Industrial Areas Development Board (KIADB) on lease cm sale basis. 1999 - The Company has set up facilities for manufacture of finished pharmaceutical formulations during the year. 2000 - The Company has entered into agreement with CDSL & NSDL for dematerialisation. 2003 - The company has started commercial production at its unit at Pondicherry. 2011 - The company have recommended dividend @12% on the equity shares of Rs. 10/- each. 2012 - The company have recommended dividend @15% on the equity shares of Rs. 10/- each. 2013 - The company have recommended dividend @15% on the equity shares of Rs. 10/- each. 2014 - The company have recommended dividend @15% on the equity shares of Rs. 10/- each. 2015 -Natural Capsules to acquire 40% shares from Supreem Pharmaceuticals Mysore Pvt Ltd. -Natural capsules adds exclusive manufacturing line for HPMC vegetarian capsules. -Natural Capsules to boost manufacturing capacity of Gelatin capsules at its Pondicherry unit. 2021 -The company issued rights shares of 1:2 at a premium of Rs. 90 per share. 2024 -The Company Commencement Of Commercial Production In High Speed HPMC Line.
YEAR EVENTS 1993 - Natural Capsules Limited was incorporated as a Public Limited Copmany on 20th September with the Registrar of Companies, Karnataka at Bangalore. The company has obtained the Certificate of Commencement of business on the 19th January 1994. - The immediate objective of the company is to set up manufacturing facilities for manufacture of Empty Hard Gelatine Capsules with an installed capacity of 980 million Nos. per annum. 1995 - The Company has acquired land admeasuring 8165 sq. mtrs. from Karnataka Industrial Areas Development Board (KIADB) on lease cm sale basis. 1999 - The Company has set up facilities for manufacture of finished pharmaceutical formulations during the year. 2000 - The Company has entered into agreement with CDSL & NSDL for dematerialisation. 2003 - The company has started commercial production at its unit at Pondicherry. 2011 - The company have recommended dividend @12% on the equity shares of Rs. 10/- each. 2012 - The company have recommended dividend @15% on the equity shares of Rs. 10/- each. 2013 - The company have recommended dividend @15% on the equity shares of Rs. 10/- each. 2014 - The company have recommended dividend @15% on the equity shares of Rs. 10/- each. 2015 -Natural Capsules to acquire 40% shares from Supreem Pharmaceuticals Mysore Pvt Ltd. -Natural capsules adds exclusive manufacturing line for HPMC vegetarian capsules. -Natural Capsules to boost manufacturing capacity of Gelatin capsules at its Pondicherry unit. 2021 -The company issued rights shares of 1:2 at a premium of Rs. 90 per share. 2024 -The Company Commencement Of Commercial Production In High Speed HPMC Line.
Read More
Parent Organisation
Natural Capsules Ltd.
Founded
20/09/1993
Managing Director
Mr.Sunil Laxminarayana Mundra
NSE Symbol
NATCAPSUQEQ
FAQ
The current price of Natural Capsules Ltd is ₹ 154.50.
The 52-week high for Natural Capsules Ltd is ₹ 157.35 and the 52-week low is ₹ 150.00.
The market capitalization of Natural Capsules Ltd is currently ₹ 160.85. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Natural Capsules Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Natural Capsules Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Natural Capsules Ltd shares.
The CEO of Natural Capsules Ltd is Mr.Sunil Laxminarayana Mundra, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
